Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate Cancer

Share this content:

Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate Cancer

Sponsors and Collaborators
USC/Norris Comprehensive Cancer Center
Novartis
Genentech
University of Southern California

Contact
Melena Taylor
310-272-7640
melena.taylor@usc.edu

Olga Castellanos, BS
310-272-7640
ocastell@usc.edu

ClinicalTrials.gov identifier
NCT00574769

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters